Streetbeat News

AYURF

Ayurcann Holdings Corp

Industry

Offices of Other Holding Companies

Open

0.02

Mkt cap

4.1M

Volume

High

0.02

P/E Ratio

-2.08

52-wk high

0.12

Low

0.02

Div yield

N/A

52-wk low

0.01

Ayurcann Holdings Corp. reported record sales growth of $14,760,268 for Q1 2025, highlighting its strong performance in the cannabis processing and manufacturing sector. The company specializes in cannabis 2.0 and 3.0 products.

Portfolio Pulse from

November 28, 2024 | 12:15 pm

Ayurcann Holdings Corp. has terminated its business combination with Arogo Capital Acquisition Corporation due to Arogo's failure to meet certain covenants. Arogo is required to pay a $250,000 fee to Ayurcann, which disputes any payment demand from Arogo.

Portfolio Pulse from

November 21, 2024 | 2:15 pm

Ayurcann Holdings Corp., a Canadian cannabis company, reported record gross revenue of CA$45.27 million for fiscal year 2024, marking a 100% increase year-over-year. Despite challenges in the competitive cannabis market, Ayurcann expanded its market share with over 70% penetration in dispensaries and a diverse product range. The company also reported a net revenue of CA$25.16 million and an adjusted EBITDA gain of CA$198,213. Ayurcann shares closed flat at $0.054 per share.

Portfolio Pulse from Nina Zdinjak

October 29, 2024 | 1:32 pm

Ayurcann Holdings Corp. and Arogo Capital Acquisition Corporation have entered into a definitive business combination agreement, resulting in a combined entity valued at $210 million. The merger is expected to close in the second half of 2024, subject to regulatory and shareholder approvals.

Portfolio Pulse from Nina Zdinjak

June 28, 2024 | 1:57 pm

Ayurcann Holdings Corp. reported a 127.7% YoY revenue growth for Q3, with net revenue of CA$6.49 million. The company also saw a significant improvement in gross revenue, net loss, and adjusted EBITDA. Shares closed 1.21% higher at $0.03 per share.

Portfolio Pulse from Nina Zdinjak

May 28, 2024 | 12:37 pm

A recent report highlights the potential for Canadian cannabis companies' valuations to soar by up to 300% with proposed excise tax reforms. The Canadian government is considering revising the 2018 excise tax framework, which currently imposes a 30-40% tax rate on companies' domestic gross revenues, significantly higher than the intended 10%. Analyst Pablo Zuanic's report suggests that reducing the tax rate to 10% could alleviate financial strains on companies like Ayurcann, Decibel, and Village Farms, potentially doubling or even tripling their valuations. The report will be further discussed at the Benzinga Cannabis Capital Conference.

Portfolio Pulse from Nicolás Jose Rodriguez

March 26, 2024 | 1:36 pm

Ayurcann Holdings Corp. reported an 81% increase in Q2 net revenue to CA$5.8 million, with a net loss growing to CA$771,622. The company, focusing on derivative cannabis products, expanded its product range in Canada. Despite higher revenues, expenses rose to CA$2.7 million, and gross margin decreased to 37%. For the first half of fiscal 2024, net revenue was CA$12.3 million, with a slight reduction in net loss to CA$951,267. Ayurcann plans to launch new products and acquire cannabis brands, indicating growth and expansion efforts.

Portfolio Pulse from Jelena Martinovic

February 28, 2024 | 6:51 pm

Ayurcann Holdings Corp (OTCQB:AYURF), a Canadian cannabis extraction company, reported a significant increase in net revenue for Q1 2024, reaching CA$6.5 million, compared to CA$2 million in the same period last year. The company also reported a reduced net loss of CA$180 thousand and a substantial increase in gross profit to CA$2.3 million. Ayurcann's gross revenue surged by 249% to CA$11.9 million, maintaining a gross margin of 35%. The company's cash reserves improved, and it is entering the infused pre-roll sector, with the CEO expressing confidence in gaining market share.

Portfolio Pulse from Patricio Liddle

November 29, 2023 | 5:31 pm

Canadian cannabis extraction company Ayurcann Holdings Corp. reported a 102% YoY increase in gross revenue to $16.2 million for the year ended June 30, 2023. The company's net revenue totaled $12.5 million, up from $9.4 million in fiscal 2022. However, the operating loss grew to $5.3 million, up from $3.3 million in the prior year. The company's shares traded 12.8% lower at $0.0109 per share after the market close on Monday.

Portfolio Pulse from Jelena Martinovic

October 31, 2023 | 3:32 pm

Ayurcann Holdings Corp. (OTCQB:AYURF) reported Q3 2023 financial results, with gross revenues of CA $5.9 million (US $4.3 million), a 114% increase compared to the same period last year. The company has expanded its product offerings to 60 SKUs and achieved Canadian retail penetration of over 65%.

Portfolio Pulse from Maureen Meehan

May 29, 2023 | 1:25 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.